top of page

Research and Academic Activities

At Valley Advanced Lung Diseases Institute (VALDI), our commitment to advancing pulmonary health transcends beyond clinical care. Our research division is at the forefront of exploring innovative treatments and breakthrough therapies.

Research Collaboration:
VALDI Inc and The Medical Research Group
on PROSERA

medicalLogo2.webp

At VALDI Inc, in partnership with The Medical Research Group, we are engaged in a significant research study titled "Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)."
This study is a crucial step in advancing the understanding and treatment of Pulmonary Arterial Hypertension (PAH).
 

For a concise overview of the study and to gain in-depth insights, we encourage you to visit the following links:
 

  1. View the study on ClinicalTrials.gov

  2. Read more at Gossamer Bio
     

These resources provide valuable information for those interested in the latest developments in pulmonary health research. Stay informed and engaged with our ongoing efforts to improve the lives of those affected by PAH.

bottom of page